These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15095297)

  • 21. Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells.
    Wang P; Lushnikova T; Odvody J; Greiner TC; Jones SN; Eischen CM
    Oncogene; 2008 Mar; 27(11):1590-8. PubMed ID: 17828300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.
    Boström H; Leuchowius KJ; Hallböök H; Nordgren A; Thörn I; Thorselius M; Rosenquist R; Söderberg O; Sundström C
    Eur J Haematol; 2008 Sep; 81(3):218-25. PubMed ID: 18510704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.
    Pienkowska-Grela B; Witkowska A; Grygalewicz B; Rymkiewicz G; Rygier J; Woroniecka R; Walewski J
    Cancer Genet Cytogenet; 2005 Jan; 156(2):114-21. PubMed ID: 15642390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis.
    Grabow S; Kelly GL; Delbridge AR; Kelly PN; Bouillet P; Adams JM; Strasser A
    Cell Death Dis; 2016 Mar; 7(3):e2132. PubMed ID: 26962682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
    Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
    Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
    Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
    Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.
    Zimonjic DB; Ullmannova-Benson V; Factor VM; Thorgeirsson SS; Popescu NC
    Cancer Genet Cytogenet; 2009 May; 191(1):17-26. PubMed ID: 19389504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental context determines latency of MYC-induced tumorigenesis.
    Beer S; Zetterberg A; Ihrie RA; McTaggart RA; Yang Q; Bradon N; Arvanitis C; Attardi LD; Feng S; Ruebner B; Cardiff RD; Felsher DW
    PLoS Biol; 2004 Nov; 2(11):e332. PubMed ID: 15455033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
    Opavsky R; Tsai SY; Guimond M; Arora A; Opavska J; Becknell B; Kaufmann M; Walton NA; Stephens JA; Fernandez SA; Muthusamy N; Felsher DW; Porcu P; Caligiuri MA; Leone G
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15400-5. PubMed ID: 17881568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
    Haupt Y; Harris AW; Adams JM
    Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis.
    Fest T; Mougey V; Dalstein V; Hagerty M; Milette D; Silva S; Mai S
    Oncogene; 2002 May; 21(19):2981-90. PubMed ID: 12082528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo.
    Devlin JR; Hannan KM; Ng PY; Bywater MJ; Shortt J; Cullinane C; McArthur GA; Johnstone RW; Hannan RD; Pearson RB
    FEBS J; 2013 Nov; 280(21):5307-16. PubMed ID: 23331925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene.
    Cameron ER; Morton J; Johnston CJ; Irvine J; Bell M; Onions DE; Neil JC; Campbell M; Blyth K
    Cell Death Differ; 2000 Jan; 7(1):80-8. PubMed ID: 10713723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent chromosomal rearrangements implicate oncogenes contributing to T-cell lymphomagenesis in Lck-MyrAkt2 transgenic mice.
    Timakhov RA; Tan Y; Rao M; Liu Z; Altomare DA; Pei J; Wiest DL; Favorova OO; Knepper JE; Testa JR
    Genes Chromosomes Cancer; 2009 Sep; 48(9):786-94. PubMed ID: 19530243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The glucocorticoid receptor is increased in Atm-/- thymocytes and in Atm-/- thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression.
    Yan M; Kuang X; Scofield VL; Shen J; Lynn WS; Wong PK
    Steroids; 2007 May; 72(5):415-21. PubMed ID: 17418878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
    Blyth K; Vaillant F; Hanlon L; Mackay N; Bell M; Jenkins A; Neil JC; Cameron ER
    Cancer Res; 2006 Feb; 66(4):2195-201. PubMed ID: 16489021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.